Timing for clinical trials for stem cell therapy in spinal cord injuries is right, review suggests

Regenerative medicine in spinal cord injuries (SCI) is proving to help the human body create new cell and nerve connections that are severed during this type of injury. A new review provide evidence that supports researchers moving beyond the lab to conduct human clinical trials for stem cells.

Read the whole article on Science Daily

More from Science Daily